Year over year for the nine-month period, revenues increased 11.2% to $10.3 billion while expenses grew by 8.2% to $10.2 billion, according to financial documents published Nov. 20. Salaries, benefits and contract labor increased 6.4% to $4.5 billion and supply costs rose 12% to $1.7 billion.
After including the performance of its investment portfolio and other nonoperating items, the 30-hospital system ended the nine-month period with a net income of $425.3 million, compared with a net loss of $839.1 million during the same period in 2022.
Cash, cash equivalents and restricted cash were $1.2 billion for the nine months ending Sept. 30, down from $1.3 billion in the prior-year period.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
